Albany, New York, May 24, 2018: A new research study titled, “Neuroprotection Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” has been added to the comprehensive repository of Market Research Reports Search Engine (MRRSE). According to the research study, the global neuroprotection market was valued at nearly US$ 47 Bn in 2016, and is likely to grow at over 8% by the end of 2025.
The research study offers in-depth analysis and insights on the neuroprotection market, highlighting the key drivers, restraints, opportunities, and threats impacting the growth of the market. According to the research study, increasing prevalence of Alzheimer’s, macular sclerosis, and other neurological conditions is likely to provide an impetus to the growth of the market.
The research report also offers in-depth insights on the impact of increasing neurodegenerative diseases on the growth of neuroprotection market. The management of neurodegenerative diseases such as cerebral ischemia and central nervous trauma is likely to provide significant growth opportunities to stakeholders in this market.
By application, the research study offers forecast and analysis on the basis of prevention and treatment. According to the research study, rising emphasis on treatment based approach is likely to provide an impetus to growth during the assessment period. Leading pharmaceutical and research companies are focusing on developing effective treatment for a range of neurodegenerative diseases, which is likely to provide an impetus to growth during the assessment period.
The market intelligence study also offers in-depth region-wise analysis and insights. According to the study, North America is likely to maintain its lead as one of the leading markets for neuroprotection globally. The adoption of these services in North America is likely to remain concentrated in the US, with Canada accounting for a minor share of the market.
In addition to North America, Asia Pacific is also likely to provide sizeable growth opportunities to manufacturers during the assessment period. Many countries in Asia Pacific are emerging as lucrative medical tourism hubs, and this is likely to provide an impetus to growth during the assessment period. The growing emphasis on providing quality healthcare services is likely to augur well for the prospects of neuroprotection market globally.
The market intelligence study also offers in-depth analysis and insights on the prevailing competitive landscape in the market. According to the research study, some of the leading companies in the neuroprotection market include Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company, Allergan plc, Eli Lilly and Company, Dr. Reddy’s Laboratories Ltd., Novartis AG, F. Hoffmann-La Roche AG, AstraZeneca plc, Astrocyte Pharmaceuticals, Inc., and Biogen Inc.
Browse Full Global Neuroprotection Market Report with TOC : https://www.mrrse.com/neuroprotection-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207